They found that MEFV mutations were significantly more prevalent in both AA-FMF (81%) and non-AA-FMF (62.7%) patients compared to healthy controls (4.2%), and in AA-FMF compared to non-AA-FMF patients (178). This evidence concerns the gene MEFV and familial Mediterranean fever.